Equillium Inc (NASDAQ: EQ) closed the day trading at $2.23 down -10.80% from the previous closing price of $2.50. In other words, the price has decreased by -$0.2700 from its previous closing price. On the day, 590653 shares were traded. EQ stock price reached its highest trading level at $2.4886 during the session, while it also had its lowest trading level at $2.1110.
Ratios:
For a better understanding of EQ, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.06 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.23. For the most recent quarter (mrq), Quick Ratio is recorded 1.91 and its Current Ratio is at 1.91. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.02.
On September 15, 2021, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $14.
H.C. Wainwright reiterated its Buy rating for the stock on July 14, 2020, while the target price for the stock was revised from $14 to $24.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EQ now has a Market Capitalization of 87.80M and an Enterprise Value of 42.42M. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.15 while its Price-to-Book (P/B) ratio in mrq is 3.25. Its current Enterprise Value per Revenue stands at 0.99 whereas that against EBITDA is -6.27.
Stock Price History:
Over the past 52 weeks, EQ has reached a high of $3.25, while it has fallen to a 52-week low of $0.45. The 50-Day Moving Average of the stock is 1.2790, while the 200-Day Moving Average is calculated to be 0.8408.
Shares Statistics:
Over the past 3-months, EQ traded about 357.88K shares per day on average, while over the past 10 days, EQ traded about 500.6k shares per day. A total of 34.41M shares are outstanding, with a floating share count of 10.70M. Insiders hold about 51.30% of the company’s shares, while institutions hold 12.03% stake in the company. Shares short for EQ as of Feb 15, 2024 were 306.46k with a Short Ratio of 0.86, compared to 503.41k on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.87% and a Short% of Float of 1.40%.
Earnings Estimates
Current recommendations for the stock of the company come from 0 analysts. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$0.02. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.
Revenue Estimates
1 analysts predict $8M in revenue for the current quarter. It ranges from a high estimate of $8M to a low estimate of $8M. As of the current estimate, Equillium Inc’s year-ago sales were $2.91M, an estimated increase of 174.50% from the year-ago figure.
A total of 1 analysts have provided revenue estimates for EQ’s current fiscal year. The highest revenue estimate was $34M, while the lowest revenue estimate was $34M, resulting in an average revenue estimate of $34M. In the same quarter a year ago, actual revenue was $10.98M, up 209.70% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $24M in the next fiscal year. The high estimate is $24M and the low estimate is $24M. The average revenue growth estimate for next year is down -29.40% from the average revenue estimate for this year.
